Prospective Pilot Study of Consolidation Chemotherapy With Docetaxel and Cisplatin After Concurrent Chemoradiotherapy for Advanced Head and Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 1, 2008, Pages 187-191

  Lee, Kyun Chan ^a   Lee, Seok Ho ^a   Lee, Yuna ^a   Park, Se Hoon ^a   Park, Jinny ^a   Cho, Eun Kyung ^a   Shin, Dong Bok ^a   Lee, Jae Hoon ^a   Kim, Dong Young ^a   Kim, Seon Tae ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Cisplatin; Consolidation chemotherapy; Docetaxel; Head and neck cancer

Indexed keywords

DOSIMETRY; FAILURE ANALYSIS; ONCOLOGY; PATIENT MONITORING; PROBLEM SOLVING; RADIOTHERAPY; TUMORS;

CISPLATIN; CONSOLIDATION CHEMOTHERAPY; DOCETAXEL; HEAD AND NECK CANCER;

CHEMOTHERAPY;

CISPLATIN; DEXAMETHASONE; DOCETAXEL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG FATALITY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEAD AND NECK CANCER; HUMAN; LEUKOPENIA; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; SEPSIS; STOMATITIS; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; TAXOIDS;

EID: 41749110043     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.09.023     Document Type: Article

References (18)

1. Kramer S., Gelber R.D., Snow J.B., et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10 (1987) 19-30
2. Vokes E.E., Weichselbaum R.R., Lippman S.M., et al. Head and neck cancer. N Engl J Med 328 (1993) 184-194
3. Forastiere A., Koch W., Trotti A., et al. Head and neck cancer. N Engl J Med 345 (2001) 1890-1900
4. Argiris A. Update on chemoradiotherapy for head and neck cancer. Curr Opin Oncol 14 (2002) 323-329
5. Argiris A., Haraf D.J., Kies M.S., et al. Intensive concurrent chemoradiotherapy for head and neck cancer with 5-fluorouracil- and hydroxyurea-based regimens: Reversing a pattern of failure. Oncologist 8 (2003) 350-360
6. Specht L., Larsen S.K., and Hansen H.S. Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck. Ann Oncol 11 (2000) 845-849
7. Caponigro F., Massa E., Manzione L., et al. Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG). Ann Oncol 12 (2001) 199-202
8. Gedlicka C., Formanek M., Selzer E., et al. Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck. Oncology 63 (2002) 145-150
9. Baur M., Kienzer H.R., Schweiger J., et al. Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma: A phase II trial. Cancer 94 (2002) 2953-2958
10. Glisson B.S., Murphy B.A., Frenette G., et al. Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. J Clin Oncol 20 (2002) 1593-1599
11. Posner M.R., and Lefebvre J.L. Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck. Br J Cancer 88 (2003) 11-17
12. Fonseca E., Grau J.J., Sastre J., et al. Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: A randomised phase II study. Eur J Cancer 41 (2005) 1254-1260
13. Bryant J., and Day R. Incorporating toxicity considerations into the design of two-stage phase II clinical trials. Biometrics 51 (1995) 1372-1383
14. Argiris A., Jayaram P., and Pichardo D. Revisiting induction chemotherapy for head and neck cancer. Oncology (Williston Park) 19 (2005) 759-770
15. Taylor S.G.t. Why has so much chemotherapy done so little in head and neck cancer?. J Clin Oncol 5 (1987) 1-3
16. Belani C.P., Choy H., Bonomi P., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23 (2005) 5883-5891
17. Gandara D.R., Chansky K., Albain K.S., et al. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group Study S9504. J Clin Oncol 21 (2003) 2004-2010
18. Vera-Llonch M., Oster G., Hagiwara M., et al. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106 (2006) 329-336